Author
Listed:
- Michael A. P. Bloomfield
(Psychiatric Imaging Group, Robert Steiner MR Unit, MRC Clinical Sciences Centre, Institute of Clinical Sciences, Imperial College London, Hammersmith Hospital
Psychiatric Imaging Group, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, Du Cane Road
University College London, 6th Floor, Maple House
Institute of Psychiatry, Psychology & Neuroscience, Kings College London)
- Abhishekh H. Ashok
(Psychiatric Imaging Group, Robert Steiner MR Unit, MRC Clinical Sciences Centre, Institute of Clinical Sciences, Imperial College London, Hammersmith Hospital
Psychiatric Imaging Group, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, Du Cane Road
Institute of Psychiatry, Psychology & Neuroscience, Kings College London)
- Nora D. Volkow
(National Institute on Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, Bethesda, Maryland 20892-9561, USA)
- Oliver D. Howes
(Psychiatric Imaging Group, Robert Steiner MR Unit, MRC Clinical Sciences Centre, Institute of Clinical Sciences, Imperial College London, Hammersmith Hospital
Psychiatric Imaging Group, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, Du Cane Road
Institute of Psychiatry, Psychology & Neuroscience, Kings College London)
Abstract
The effects of Δ9-tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, are a pressing concern for global mental health. Patterns of cannabis use are changing drastically owing to legalization, the availability of synthetic analogues (commonly termed spice), cannavaping and an emphasis on the purported therapeutic effects of cannabis. Many of the reinforcing effects of THC are mediated by the dopamine system. Owing to the complexity of the cannabinoid–dopamine interactions that take place, there is conflicting evidence from human and animal studies concerning the effects of THC on the dopamine system. Acute THC administration causes increased dopamine release and neuron activity, whereas long-term use is associated with blunting of the dopamine system. Future research must examine the long-term and developmental dopaminergic effects of THC.
Suggested Citation
Michael A. P. Bloomfield & Abhishekh H. Ashok & Nora D. Volkow & Oliver D. Howes, 2016.
"The effects of Δ9-tetrahydrocannabinol on the dopamine system,"
Nature, Nature, vol. 539(7629), pages 369-377, November.
Handle:
RePEc:nat:nature:v:539:y:2016:i:7629:d:10.1038_nature20153
DOI: 10.1038/nature20153
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:539:y:2016:i:7629:d:10.1038_nature20153. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.